据研究发现,新型胆固醇药物奥比塞特拉皮可能大大降低心脏病发作和中风风险. New cholesterol drug Obicetrapib may greatly lower heart attack and stroke risk, study finds.

由Monash大学牵头的一项国际研究发现,一种新的胆固醇低落药物 " Obicetrapib " 可能大大减少高危人群的心脏病发作和中风风险。 An international study led by Monash University found that a new cholesterol-lowering drug, Obicetrapib, may significantly reduce heart attack and stroke risk for high-risk individuals. 一次日服用的避孕药降低LDL胆固醇和脂质蛋白(a),这是心血管疾病的关键因素。 The once-daily pill lowers both LDL cholesterol and lipoprotein(a), key factors in cardiovascular disease. 在对2 500多名参与者进行测试后,发现该药物是有效且经良好许可的,有可能为那些努力用现有药物来管理胆固醇水平的人提供新的治疗选择。 Tested on over 2,500 participants, the drug was found to be effective and well-tolerated, potentially offering a new treatment option for those struggling to manage cholesterol levels with current medications.